Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000933
Chunk: 71

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 71
---
 the Investor shall promptly furnish to the Company such
information regarding itself, the Registrable Securities held by it and the intended method of disposition of the Registrable Securities
held by it as shall be reasonably required to effect the registration of such Registrable Securities and shall execute such documents
in connection with such registration as the Company may reasonably request.

b. The
Investor agrees to cooperate with the Company as reasonably requested by the Company in connection with the preparation and filing of
any Registration Statement hereunder and any amendments and supplements thereof.

c. The
Investor agrees that, upon receipt of any notice from the Company of the happening of any event or existence of facts of the kind described
in or the first sentence of , the Investor will immediately discontinue disposition of Registrable Securities
pursuant to any Registration Statement(s) covering such Registrable Securities until the Investor’s receipt of the copies of a notice
regarding the resolution or withdrawal of the stop order or suspension as contemplated by or the supplemented or amended
prospectus as contemplated by the first sentence of Section 3(e. Notwithstanding anything to the contrary, the Company shall direct
the Depositary to promptly deliver Depositary Shares without any restrictive legend in accordance with the terms of the Purchase Agreement
in connection with any sale of Registrable Securities with respect to which an Investor has entered into a contract for sale prior to
the Investor’s receipt of a notice from the Company of the happening of any event of the kind described in or
the first sentence of and for which the Investor has not yet settled.

5. .

Except as provided in the Purchase
Agreement, all reasonable expenses of the Company, incurred in connection with registrations, filings or qualifications pursuant to and , including, without limitation, all registration, listing and qualifications fees, printers and accounting fees, and
fees and disbursements of counsel for the Company, shall be paid by the Company. For the avoidance of doubt, sales or brokerage commissions
and fees and disbursements of counsel for, and other expenses of, the Investor, shall be paid by the Investor, except as may be expressly
set forth in the Purchase Agreement.

| 6 |

6. .

a. To
the fullest extent permitted by law, the Company will, and hereby does, indemnify, hold harmless and defend the Investor, each Person,
if any, who controls the Investor, the members, the directors, officers, partners, employees, agents, representatives of the Investor
and each Person, if any, who